NEW YORK (GenomeWeb News) – Personalized medicine may not be able to live up to its promise as long as the pharmaceutical industry is focused on blockbuster drugs, according to a new white paper from the Kauffman Foundation, which argues that small biotechs working in this field should begin to look to non-profit organizations to help fund their studies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.